Sabra Health Care REIT, Inc.
SBRA
$21.10
$0.130.62%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.27% | -1.93% | -0.31% | 2.52% | 3.65% |
| Total Other Revenue | 32.30% | 25.06% | 21.33% | 20.25% | 20.27% |
| Total Revenue | 13.25% | 10.41% | 9.34% | 10.21% | 10.76% |
| Cost of Revenue | 27.40% | 19.38% | 15.12% | 15.00% | 15.09% |
| Gross Profit | 6.52% | 6.15% | 6.66% | 8.05% | 8.81% |
| SG&A Expenses | 9.70% | 7.28% | -5.36% | -2.67% | 4.19% |
| Depreciation & Amortization | 15.53% | 10.24% | 4.53% | 0.82% | -1.72% |
| Other Operating Expenses | 24,046.77% | 24,046.77% | -- | -- | -- |
| Total Operating Expenses | 24.25% | 17.89% | 8.83% | 7.21% | 6.95% |
| Operating Income | -5.42% | -2.59% | 10.28% | 15.68% | 17.89% |
| Income Before Tax | 11.46% | 23.20% | 79.86% | 238.78% | 176.68% |
| Income Tax Expenses | 102.07% | 82.79% | 54.38% | -44.23% | -44.12% |
| Earnings from Continuing Operations | 10.84% | 22.73% | 80.15% | 248.73% | 184.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.96% | 22.81% | 80.17% | 248.73% | 184.38% |
| EBIT | -5.42% | -2.59% | 10.28% | 15.68% | 17.89% |
| EBITDA | 2.76% | 2.54% | 8.26% | 9.81% | 9.78% |
| EPS Basic | 7.23% | 19.67% | 76.02% | 240.70% | 179.29% |
| Normalized Basic EPS | 4.16% | 12.90% | 30.33% | 42.30% | 35.47% |
| EPS Diluted | 5.94% | 19.48% | 78.62% | 264.11% | 197.25% |
| Normalized Diluted EPS | 3.86% | 12.66% | 29.98% | 41.59% | 34.72% |
| Average Basic Shares Outstanding | 4.15% | 3.34% | 2.56% | 2.29% | 1.65% |
| Average Diluted Shares Outstanding | 4.47% | 3.58% | 2.89% | 2.83% | 2.23% |
| Dividend Per Share | -25.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.06% | -0.16% | -0.43% | -0.71% | -0.64% |